BSFA BSF Enterprise Plc
BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing, and e-commerce sectors. It also engages in biotechnology start-up; lab-grown cornea and meat research; and development of skin technology. In addition, the company engages in the humanoid robotics and physical AI platform designed to address the outer-covering and tactile sensor integration facing volume robotics manufacturing. The company was incorporated in 2018 and is based in London, the United Kingdom.…
Industry Peers
BiotechnologyKey Statistics
About BSF Enterprise (LON: BSFA)
›
BSF Enterprise (LON: BSFA) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 14 employees.
The shares were at 0.9000 GBp on 19 November 2026, down 71.4% over 52 weeks.
Its market capitalisation is 1.83M GBP.
BSF Enterprise reports return on equity of -41.0% and revenue down 8.6% year over year.
Its debt exceeds its cash by 722.15K GBP. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.